Physician profile
Joseph Tyler Cox
NPI 1609163682
$83,727.28
in general payments reported to CMS, 2019-2025
22 companies · $21K in 2025
The $21K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,718 · 2020: $24.84 · 2021: $19K · 2022: $5,925 · 2023: $16K · 2024: $17K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Travel and Lodging: $16K · Food and Beverage: $2,547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,900.00 |
| Travel and Lodging | $16,465.62 |
| Food and Beverage | $2,547.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $80,326.36 | 2019-2025 | Other - Miscellaneous, Battalion Plif - Ps, Solanas |
| Alon Medical Technology | $743.14 | 2025 | |
| Arthrex, INC. | $616.40 | 2025 | |
| Globus Medical, INC. | $506.86 | 2019 | |
| Smith+Nephew, INC. | $206.25 | 2021 | |
| Stryker Corporation | $170.82 | 2019 | |
| Sanara Medtech INC. | $168.08 | 2023 | Celleraterx |
| Providence Medical Technology, INC. | $151.84 | 2019-2025 | |
| Depuy Synthes Sales INC. | $149.40 | 2021-2025 | Na |
| Horizon Therapeutics Plc | $134.30 | 2020-2022 | |
| Djo, LLC | $114.44 | 2024-2025 | Cmf |
| Vertex Pharmaceuticals Incorporated | $93.73 | 2025 | |
| Spinal Simplicity, LLC | $86.33 | 2019 | |
| Abbott Laboratories | $67.52 | 2025 | Eterna |
| Next Science LLC | $61.70 | 2024 | Blastx, Xperience, Surgx |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 4web, INC. | $31.11 | 2024 | Spine Truss System |
| Radius Health, INC. | $23.85 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.69 | 2025 | Zilretta, Iovera |
| Pacira Therapeutics, INC. | $15.73 | 2019 | |
| Boston Scientific Corporation | $15.56 | 2024 | Wavewriter Alpha Prime 16 |
| Sanofi-Aventis U.S. LLC | $14.65 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.